Five-year Follow-Up of a Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy in CLL
Inhye E. Ahn,Danielle M. Brander,Yue Ren,Yinglu Zhou,Svitlana Tyekucheva, Heather A. Walker,Robert Black,Josie Montegaard,Alvaro Alencar,Leyla Shune,Mohammad Omaira,Caron A. Jacobson,Philippe Armand,Samuel Y. Ng,Jennifer Crombie,David C. Fisher,Ann S. LaCasce,Jon Arnason,Ephraim P. Hochberg,Ronald W. Takvorian,Jeremy S. Abramson,Jennifer R. Brown,Matthew S. Davids Blood advances（2024）
AI 理解论文
溯源树
样例
